Abstract:Targeting the non-nuclear estrogen receptor (ER) signaling has been postulated as novel therapeutic strategy for central nervous system pathologies. Recently, we showed that newly designed PaPE-1 (Pathway Preferential Estrogen-1), which selectively activates ER non-nuclear signaling pathways, elicited neuroprotection in a cellular model of Alzheimer's disease (AD) when it was applied at the same time as amyloid-β (Aβ). Since delayed treatment reflects clinical settings better than cotreatment does, current basic study proposes a novel therapeutic approach for AD that relies on a posttreatment with PaPE-1. In this study, mouse neuronal cell cultures treated with preaggregated Aβ1-42 (10 µM) showed the presence of extracellular Aβ1-42, confirming the adequacy of the AD model used. We are the first to demonstrate that a 24-h delayed posttreatment with PaPE-1 decreased the degree of Aβ-induced neurodegeneration, restored neurite outgrowth, and inhibited the expression of AD-related genes, i.e., Rbfox, Apoe, Bace2, App, and Ngrn, except for Chat, which was stimulated. In addition, PaPE-1 elicited anti-apoptotic effects by inhibiting Aβ-induced caspase activities as well as attenuating apoptotic chromatin condensation, and in these ways, PaPE-1 prevented neuronal cell death. Posttreatment with PaPE-1 also downregulated the Aβ-affected mRNA expression of apoptosis-specific factors, such as Bax, Gsk3b, Fas, and Fasl, except for Bcl2, which was upregulated by PaPE-1. In parallel, PaPE-1 decreased the protein levels of BAX, FAS, and FASL, which were elevated in response to Aβ. PaPE-1 elicited a decrease in the BAX/BCL2 ratio that corresponds to increased methylation of the Bax gene. However, the PaPE-1-evoked Bcl2 gene hypermethylation suggests other PaPE-1-dependent mechanisms to control Aβ-induced apoptosis.

EPA-enriched Ethanolamine Plasmalogen and EPA-enriched Phosphatidylethanolamine Enhance BDNF/TrkB/CREB Signaling and Inhibit Neuronal Apoptosis in Vitro and in Vivo.

EPA Enriched Ethanolamine Plasmalogens Significantly Improve Cognition of Alzheimer’s Disease Mouse Model by Suppressing Β-Amyloid Generation

A Comparative Study about the Neuroprotective Effects of EPA-Enriched Phosphoethanolamine Plasmalogen and Phosphatidylethanolamine Against Oxidative Damage in Primary Hippocampal Neurons

Electroacupuncture promotes the survival and synaptic plasticity of hippocampal neurons and improvement of sleep deprivation-induced spatial memory impairment

A Comparative Study of EPA-enriched Ethanolamine Plasmalogen and EPA-enriched Phosphatidylethanolamine on Aβ42 Induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease

Eicosapentaenoic Acid Enriched Phosphatidylcholine Mitigated Aβ1-42 Induced Neurotoxicity Via Autophagy-Inflammasome Pathway.

Involvement of Akt/CREB signaling pathways in the protective effect of EPA against interleukin-1β-induced cytotoxicity and BDNF down-regulation in cultured rat hippocampal neurons

A Comparative Study of Eicosapentaenoic Acid Enriched Phosphatidylcholine and Ethyl Ester in Improving Cognitive Deficiency in Alzheimer's Disease Model Rats.

EPA-enriched plasmalogen attenuates the cytotoxic effects of LPS-stimulated microglia on the SH-SY5Y neuronal cell line

Eicosapentaenoic Acid-Enriched Phospholipids Improve Aβ1–40-induced Cognitive Deficiency in a Rat Model of Alzheimer's Disease

Simultaneous Intake of Chlorella and Ascidian Ethanolamine Plasmalogen Accelerates Activation of BDNF–TrkB–CREB Signaling in Rats

Comparative Study of Different Polar Groups of EPA‐Enriched Phospholipids on Ameliorating Memory Loss and Cognitive Deficiency in Aged SAMP8 Mice

The Protective Effect of Eicosapentaenoic Acid-Enriched Phospholipids from Sea Cucumber Cucumaria Frondosa on Oxidative Stress in PC12 Cells and SAMP8 Mice

A Comparative Study about the Neuroprotective Effects of DHA-Enriched Phosphatidylserine and EPA-Enriched Phosphatidylserine Against Oxidative Damage in Primary Hippocampal Neurons.

L-3-n-Butylphthalide Regulates Proliferation, Migration, and Differentiation of Neural Stem Cell in Vitro and Promotes Neurogenesis in APP/PS1 Mouse Model by Regulating BDNF/TrkB/CREB/Akt Pathway

Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice Fed with High-fat Diet

A Comparative Study about EPA-PL and EPA-EE on Ameliorating Behavioral Deficits in MPTP-induced Mice with Parkinson’s Disease by Suppressing Oxidative Stress and Apoptosis

Dietary Exposure to Plasmenylethanolamine Prevents Microglia-Mediated Neuroinflammation by Enhancing Microglia Autophagy

Posttreatment with PaPE-1 Protects from Aβ-Induced Neurodegeneration Through Inhibiting the Expression of Alzheimer's Disease-Related Genes and Apoptosis Process That Involves Enhanced DNA Methylation of Specific Genes

The neuroprotection of deproteinized calf blood extractives injection against Alzheimer's disease via regulation of Nrf-2 signaling

Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition